Titan Pharmaceuticals, Inc. (TTNP)

Titan Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Cap	6	3	6	12	10	23
Market Cap Growth	20.24%	-53.77%	-44.95%	15.82%	-56.95%	115.44%
Enterprise Value	3.33	0.15	0.19	8.84	4.26	18.41
Last Close Price	4.61	3.26	8.25	15.60	20.40	65.80
PB Ratio	2.20	1.22	0.97	8.59	1.97	6.65
P/TBV Ratio	1.60	1.20	0.93	7.69	1.93	3.51
EV/EBITDA Ratio	-	30.08	1.68	45.11	19.29	63.04
Debt / Equity Ratio	-	0	0.08	0.05	0.04	0.09
Debt / EBITDA Ratio	-	-	5.05	0.95	1.35	2.77
Quick Ratio	11.20	5.99	5.41	1.13	2.30	1.49
Current Ratio	11.60	6.05	5.55	1.37	2.71	1.74
Buyback Yield / Dilution	-16.31%	-19.55%	-11.90%	-38.13%	-157.88%	-392.56%
Total Shareholder Return	-16.31%	-19.55%	-11.90%	-38.13%	-157.88%	-392.56%

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: Jun 30, 2025

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jan 1, 2000

Data Sources Report a data error